Entresto 49 MG-51 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FD11N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,374
Award facts
- Contract value 100% obligated
- $42,373.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,373.98 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Entresto 49 mg-51 mg tablets in a quantity of 180 units. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by September 26, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026.
AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal military and healthcare systems through its comprehensive DLA prime vendor vehicle. The company's extensive portfolio includes brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Entresto, a combination medication used in heart failure treatment, exemplifies the specialized pharmaceutical products the contractor provides to support military healthcare programs. The IDC structure enables flexible and recurring pharmaceutical procurements to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide, with DLA planning to establish multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts in future procurement initiatives.
Quick answers
Who was awarded contract SPE2DB25FD11N?
SPE2DB25FD11N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FD11N worth?
The government has obligated $42,374 on SPE2DB25FD11N.
Is contract SPE2DB25FD11N an order under another contract?
Yes. SPE2DB25FD11N is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB25FD11N competed?
The extent of competition for SPE2DB25FD11N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award